These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34755460)

  • 1. Lay understandings of drug-gene interactions: The right medication, the right dose, at the right time, but what are the right words?
    Meagher KM; Stuttgen Finn K; Curtis SH; Borucki J; Beck AT; Cheema AW; Sharp RR
    Clin Transl Sci; 2022 Mar; 15(3):721-731. PubMed ID: 34755460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Communicating unexpected pharmacogenomic results to biobank contributors: A focus group study.
    Meagher KM; Curtis SH; Borucki S; Beck A; Srinivasan T; Cheema A; Sharp RR
    Patient Educ Couns; 2021 Feb; 104(2):242-249. PubMed ID: 32919825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol.
    Bielinski SJ; Olson JE; Pathak J; Weinshilboum RM; Wang L; Lyke KJ; Ryu E; Targonski PV; Van Norstrand MD; Hathcock MA; Takahashi PY; McCormick JB; Johnson KJ; Maschke KJ; Rohrer Vitek CR; Ellingson MS; Wieben ED; Farrugia G; Morrisette JA; Kruckeberg KJ; Bruflat JK; Peterson LM; Blommel JH; Skierka JM; Ferber MJ; Black JL; Baudhuin LM; Klee EW; Ross JL; Veldhuizen TL; Schultz CG; Caraballo PJ; Freimuth RR; Chute CG; Kullo IJ
    Mayo Clin Proc; 2014 Jan; 89(1):25-33. PubMed ID: 24388019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.
    Ji Y; Skierka JM; Blommel JH; Moore BE; VanCuyk DL; Bruflat JK; Peterson LM; Veldhuizen TL; Fadra N; Peterson SE; Lagerstedt SA; Train LJ; Baudhuin LM; Klee EW; Ferber MJ; Bielinski SJ; Caraballo PJ; Weinshilboum RM; Black JL
    J Mol Diagn; 2016 May; 18(3):438-445. PubMed ID: 26947514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perplexed by PGx? Exploring the impact of pharmacogenomic results on medical management, disclosures and patient behavior.
    Waldman L; Shuman C; Cohn I; Kaiser A; Chitayat D; Wasim S; Hazell A
    Pharmacogenomics; 2019 Apr; 20(5):319-329. PubMed ID: 30983503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Utility of Pharmacogenomic Data Collected by a Health-System Biobank to Predict and Prevent Adverse Drug Events.
    Shah SN; Gammal RS; Amato MG; Alobaidly M; Reyes DD; Hasan S; Seger DL; Krier JB; Bates DW
    Drug Saf; 2021 May; 44(5):601-607. PubMed ID: 33620701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting.
    Cohn I; Manshaei R; Liston E; Okello JBA; Khan R; Curtis MR; Krupski AJ; Jobling RK; Kalbfleisch K; Paton TA; Reuter MS; Hayeems RZ; Verstegen RHJ; Goldman A; Kim RH; Ito S
    JAMA Netw Open; 2021 May; 4(5):e2110446. PubMed ID: 34037732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of incorporating genomic knowledge into electronic medical records for pharmacogenomic clinical decision support.
    Overby CL; Tarczy-Hornoch P; Hoath JI; Kalet IJ; Veenstra DL
    BMC Bioinformatics; 2010 Oct; 11 Suppl 9(Suppl 9):S10. PubMed ID: 21044357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usability evaluation of pharmacogenomics clinical decision support aids and clinical knowledge resources in a computerized provider order entry system: a mixed methods approach.
    Devine EB; Lee CJ; Overby CL; Abernethy N; McCune J; Smith JW; Tarczy-Hornoch P
    Int J Med Inform; 2014 Jul; 83(7):473-83. PubMed ID: 24874987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomic and pharmacogenetic-guided therapy as a tool in precision medicine: current state and factors impacting acceptance by stakeholders.
    Hess GP; Fonseca E; Scott R; Fagerness J
    Genet Res (Camb); 2015 Jun; 97():e13. PubMed ID: 26030725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population structure and pharmacogenomic risk stratification in the United States.
    Nagar SD; Conley AB; Jordan IK
    BMC Biol; 2020 Oct; 18(1):140. PubMed ID: 33050895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What Do Students in Pharmacy and Medicine Think About Pharmacogenomics and Personalized Medicine Education? Awareness, Attitudes, and Perceptions in Malaysian Health Sciences.
    Siamoglou S; Koromina M; Moy FM; Mitropoulou C; Patrinos GP; Vasileiou K
    OMICS; 2021 Jan; 25(1):52-59. PubMed ID: 33170085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary care physician experiences with integrated pharmacogenomic testing in a community health system.
    Lemke AA; Hutten Selkirk CG; Glaser NS; Sereika AW; Wake DT; Hulick PJ; Dunnenberger HM
    Per Med; 2017 Sep; 14(5):389-400. PubMed ID: 29754567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Investigation of the Knowledge Overlap between Pharmacogenomics and Disease Genetics.
    Li B; Whirl-Carrillo M; Wright MW; Babb L; Rehm HL; Klein TE
    Pac Symp Biocomput; 2022; 27():385-396. PubMed ID: 34890165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetics in the clinical analysis laboratory: clinical practice, research, and drug development pipeline.
    Miscio G; Paroni G; Bisceglia P; Gravina C; Urbano M; Lozupone M; Piccininni C; Prisciandaro M; Ciavarella G; Daniele A; Bellomo A; Panza F; Di Mauro L; Greco A; Seripa D
    Expert Opin Drug Metab Toxicol; 2019 Sep; 15(9):751-765. PubMed ID: 31512953
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing.
    van der Wouden CH; van Rhenen MH; Jama WOM; Ingelman-Sundberg M; Lauschke VM; Konta L; Schwab M; Swen JJ; Guchelaar HJ
    Clin Pharmacol Ther; 2019 Oct; 106(4):866-873. PubMed ID: 31038729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Making pharmacogenomic-based prescribing alerts more effective: A scenario-based pilot study with physicians.
    Overby CL; Devine EB; Abernethy N; McCune JS; Tarczy-Hornoch P
    J Biomed Inform; 2015 Jun; 55():249-59. PubMed ID: 25957826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A semi-supervised approach to extract pharmacogenomics-specific drug-gene pairs from biomedical literature for personalized medicine.
    Xu R; Wang Q
    J Biomed Inform; 2013 Aug; 46(4):585-93. PubMed ID: 23570835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PACE Forward-Making Pharmacogenomics Testing Available for Real-Life Clinical Utility.
    Lazaridis KN
    Clin Pharmacol Ther; 2019 Jan; 105(1):42-44. PubMed ID: 30520030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-interventional cardiologists' perspectives on the role of pharmacogenomic testing in cardiovascular medicine.
    Deininger KM; Page RL; Lee YM; Kauffman YS; Johnson SG; Oreschak K; Aquilante CL
    Per Med; 2019 Mar; 16(2):123-132. PubMed ID: 30543145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.